Market Tracker

07/01 5:16pm ET

Medivation Inc (NASDAQ:MDVN)

60.12
Delayed Data
As of Jul 01
 -0.18 / -0.30%
Today’s Change
26.41
Today|||52-Week Range
62.94
+24.37%
Year-to-Date
An Overnight Double! Could These Drugmakers Be Next?
Jul 01 / MotleyFool.com - Paid Partner Content
Sanofi to Exit Animal Care in $25B Asset Swap with Boehringer
Jun 27 / TheStreet.com - Paid Partner Content
5 Hot Stocks to Watch Right Now
Jun 30 / TheStreet.com - Paid Partner Content
2 Words That Could Bring Down the Entire Prescription Drug Industry
Jun 23 / MotleyFool.com - Paid Partner Content
What Tesaro's Cancer Drug Success Means for Medivation
Jun 29 / TheStreet.com - Paid Partner Content
$18,543 Invested in This Biotech a Decade Ago Is Now Worth $1 Million
Jun 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close60.30
Today’s open60.18
Day’s range59.45 - 61.00
Volume1,611,686
Average volume (3 months)3,367,209
Market cap$9.9B
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-15.48%
Earnings growth (this year)-28.69%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+32.76%
P/E ratio39.6
Price/Sales8.68
Price/Book11.33

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+1.76+3.44%
JAZZJazz Pharmaceuticals...-0.27-0.19%
IDXXIDEXX Laboratories I...+0.21+0.23%
BMRNBiomarin Pharmaceuti...+3.58+4.60%
Data as of 4:02pm ET, 07/01/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.25
Annual revenue (last year)$943.3M
Annual profit (last year)$244.7M
Net profit margin25.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts